‌

US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors

Patent 11767323 was granted and assigned to Incyte on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yu Bai

Song Mei

Cheng-Tsung Lai

Wenqing Yao

Liangxing Wu

Leah C. Konkol

Kai Liu

Andrew W. Buesking

...

Date of Patent

September 26, 2023

Patent Application Number

17365686

Date Filed

July 1, 2021

Patent Citations

US Patent 8163767 Heterocyclic Janus Kinase 3 inhibitors

US Patent 7429456 Identification of a JAK2 mutation in Polycythemia Vera

US Patent 7781199 Identification of a JAK2 mutation involved in Vaquez Polyglobulia

US Patent 7879844 Heterocyclic janus kinase 3 inhibitors

US Patent 8524867 Optimized antibodies that target CD19

US Patent 8637235 Identification of a JAK2 mutation in polycythemia vera

US Patent 8785639 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof

US Patent 8852931 Identification of a JAK2 mutation involved in vaquez polyglobulia

...

Patent Citations Received

US Patent 12084430 Tricyclic urea compounds as JAK2 V617F inhibitors

0

US Patent 11958861 Spirocyclic lactams as JAK2 V617F inhibitors

0

Patent Primary Examiner

Charanjit Aulakh

CPC Code

Patent abstract

The present application provides tricyclic pyridone compounds that modulate the activity of the V617F variant of JAK2, which are useful in the treatment of various diseases, including cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.